Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer

A Study for the Treatment of Hormone Refractory Prostate Cancer (HRPC) in Patients Previously Treated With Chemotherapy

NCT00257478 ·Status: COMPLETED ·Phase: PHASE2

S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy

NCT00134056 ·Status: COMPLETED ·Phase: PHASE3

A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer

NCT07005154 ·Status: RECRUITING ·Phase: PHASE2

Safety and Efficacy Study of AT-101 in Combination With Docetaxel and Prednisone in Men With HRPC

NCT00286793 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Abiraterone Acetate in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer

NCT00887198 ·Status: COMPLETED ·Phase: PHASE3

Study of ATN-224 in Patients With Prostate Cancer

NCT00405574 ·Status: UNKNOWN ·Phase: PHASE2

Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer

NCT00003516 ·Status: TERMINATED ·Phase: PHASE2

Phase II Study of ASP3550 in Patients With Prostate Cancer

NCT00568516 ·Status: COMPLETED ·Phase: PHASE2

A Study to Learn About the Study Medicines Called Enzalutamide and Abiraterone in People With Metastatic Castration-resistant Prostate Cancer

NCT05968599 ·Status: COMPLETED

Study of CP-751,871 in Combination With Docetaxel and Prednisone in Patients With Hormone Insensitive Prostate Cancer (HRPC)

NCT00313781 ·Status: COMPLETED ·Phase: PHASE2

Nitrocamptothecin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy

NCT00005820 ·Status: COMPLETED ·Phase: PHASE2

S1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone Therapy

NCT01309672 ·Status: COMPLETED ·Phase: PHASE2

A Study of HSP90 Inhibitor AT13387 Alone or in Combination With Abiraterone Acetate

NCT01685268 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Investigation of Early Hormonotherapy Efficacy of Prostate Cancer

NCT00375687 ·Status: UNKNOWN ·Phase: NA

Once-daily Oral Seviteronel in Patients With Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone.

NCT02445976 ·Status: COMPLETED ·Phase: PHASE2

Trial of Acetylsalicylic Acid and Atorvastatin in Patients With Castrate-resistant Prostate Cancer

NCT03819101 ·Status: RECRUITING ·Phase: PHASE3

A Study of Abiraterone Acetate Plus Low-Dose Prednisone Plus Androgen Deprivation Therapy (ADT) Versus ADT Alone in Newly Diagnosed Participants With High-Risk, Metastatic Hormone-Naive Prostate Cancer (mHNPC)

NCT01715285 ·Status: COMPLETED ·Phase: PHASE3

MEN-10755 in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy

NCT00027781 ·Status: COMPLETED ·Phase: PHASE2

AZD0530 in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy

NCT00513071 ·Status: COMPLETED ·Phase: PHASE2

A Phase 1 Study of MDV3100 in Patients With Castration-Resistant (Hormone-Refractory) Prostate Cancer

NCT00510718 ·Status: COMPLETED ·Phase: PHASE1

Olaparib in Men With High-Risk Biochemically-Recurrent Prostate Cancer Following Radical Prostatectomy, With Integrated Biomarker Analysis

NCT03047135 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

To Evaluate the Criteria for Renewal of Luteinizing Hormone-Releasing Hormone (LHRH) Analogue Treatment in Prostate Cancer Patients

NCT03017313 ·Status: COMPLETED

Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic Adenocarcinoma

NCT03436654 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Abiraterone Acetate in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

NCT01503229 ·Status: COMPLETED ·Phase: PHASE2

A Safety and Efficacy Study of Abiraterone Acetate in Participants With Prostate Cancer Who Have Failed Hormone Therapy

NCT00473512 ·Status: COMPLETED ·Phase: PHASE1/PHASE2